Imperial College London


Faculty of MedicineDepartment of Surgery & Cancer

Senior Laboratory Manager



+44 (0)20 7594 2798yoyo.dixon









I am originally from Hong Kong and came to the UK for further education in 1999. I gained a BSc (Hons) Pharmacology with Management with an extra mural year (Johnson & Johnson R & D, Janssen Pharmaceutica) at King''s College London in 2004. During the final year of my undergraduate studies, I became interested in inflammation and related diseases . I therefore carried out my PhD studies under the supervision of Dr. David Bishop-Bailey and Prof. Tim Warner, from William Harvey Research Institute, Barts and The London, Queen Mary, University of London. The title of my thesis is "The Farnesoid X Receptor as a Regulator of Vascular Smooth Muscle Cell Inflammation and Migration". I worked as a contract-based Scientist at Pfizer UK during my writing-up period. After gaining my PhD in Pharmacology, I joined Dr. Stuart Cook''s Molecular Cardiology group at MRC-CSC, Imperial College, as a Post-Doctoral Research Associate in Summer 2008.

I have now taken on the administrative and managing role of sectional Laboratory Manager within Division of Cancer, Department of Surgery & Cancer, Imperial College. This job title might not be accurately suitable though. I am primarily based in Cyclotron Building, Hammersmith Campus. However, I have started to spend a fair amount of time in IRDB. I work closely with Nicholas Wood (the other sectional Laboratory Manager) and Roger White (Operational Manager). Should you wish to contact me, please refer to my contact details as shown above (best by email).

I am currently not directly involved in any Cancer Research studies within the Division, but I would very much love to make some significant contributions in the future. I have always had great interest in Cancer due to family medical history, and previous wee involvement in a breast cancer study.

I undertook a safety course within Imperial College during Sept. - Dec. 2010 and I have recently been awarded a credit in NEBOSH (NGC1-3).

Publications and Prizes:

Petretto et al., (2010). “A conserved trans-acting regulatory locus underlies an inflammatory gene network and susceptibility to autoimmune type 1 diabetes.” Nature; 467(7314); 460-4.

Piqueras et al., (2009). “Activation of PPARβ/δ inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release.” J Leukoc Biol; 86(1): 115-22.

Li et al., (2007). “Farnesoid X receptor ligands inhibit vascular smooth muscle cell inflammation and migration.” Arterioscler Thromb Vasc Biol; 27(12): 2606-11.

Li et al., (2006; abstract). Inhibition of MMP-2 and -9 activities by Farnesoid X receptor in vascular smooth muscle cells. pA2 online, E-Journal of the BPS; 4(2): 096P.

Li et al., (2006; abstract). Inhibition of nuclear factor (NF)-κB activity by the Farnesoid X receptor. pA2 online; E- Journal of the BPS; 4(2): 158P.

Li et al., (2005; abstract). Farnesoid X receptor ligands inhibit IL-1β stimulated iNOS activity in vascular smooth muscle cells. pA2 online, E- Journal of the BPS; 3(2): 059P.

William Harvey Poster Prize (2006; QMUL).

London Vascular Biology Forum Poster Prize (The 12th Meeting 2005; KCL).


Joint Groups Strategy Away Day (Oral; 2009; London).

The 4th EMVBM meeting (Highlighted Poster; 2007; Bristol).

07 INYS on Cardiovascular Physiology & Mechanisms of Injury & Repair (Oral; Slovakia).

BPS (3 Posters; Spring 2005 in Cambridge and Winter 2006 in Oxford).

William Harvey Conference (Poster; 2006).

The 12th CLSS-UK (Oral; 2005; London).

The 12th LVBF Meeting (Poster; 2005; London).

Summer School on Endocrinology (Poster; 2005; Austria).